AXSM stock news · Axsome Therapeutics, Inc.
Get alerts for AXSM
Follow Axsome Therapeutics, Inc. (AXSM) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for AXSMFree on the App Store and Google Play, or on the web.
Axsome Therapeutics shared its Q3 2026 financial results and updated its company presentation.
NeutralAxsome released results for the 3 months ended September 30, 2026, and updated its operations. The filing gives no figures or details, so it does not change the business outlook.
Following Q2 results, analysts boost their price targets for Axsome Therapeutics.
NeutralAxsome Therapeutics reported disappointing Q2 results with losses greater than expected, yet analysts have raised their price targets based on the company's growth potential and pipeline advancements. This mixed outcome suggests cautious optimism but does not provide a clear actionable signal.